Zerun Biotechnology Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 13

  • Investments
  • 1

Zerun Biotechnology General Information

Description

Developer of recombinant human vaccines designed for protecting people from infectious diseases. The company utilizes s protein trimer technology and CHO cell expression systems to produce bivalent hpv vaccines, recombinant COVID-19 vaccines, multi-variant vaccine candidates, prototype vaccine candidates, and recombinant human vaccines, enabling healthcare providers to access stable antigen proteins for enhanced immune response.

Contact Information

Formerly Known As
Shanghai Huisheng Biotechnology
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Building 9, Lane 1690, Zhangheng Road, Zhangjiang District
  • Pudong
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Building 9, Lane 1690, Zhangheng Road, Zhangjiang District
  • Pudong
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zerun Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zerun Biotechnology‘s full profile, request access.

Request a free trial

Zerun Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of recombinant human vaccines designed for protecting people from infectious diseases. The company utilizes s
Drug Discovery
Shanghai, China

Singapore, Singapore
 

Singapore, Singapore
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zerun Biotechnology Competitors (3)

One of Zerun Biotechnology’s 3 competitors is Hummingbird Bioscience, a Venture Capital-Backed company based in Singapore, Singapore.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hummingbird Bioscience Venture Capital-Backed Singapore, Singapore
AUM Biosciences Venture Capital-Backed Singapore, Singapore
KM Biologics Accelerator/Incubator Backed Kumamoto, Japan
You’re viewing 3 of 3 competitors. Get the full list »

Zerun Biotechnology Patents

Zerun Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023165435-A1 Recombinant spike protein, method for preparing same and use thereof Inactive 01-Mar-2022
WO-2023116374-A1 Herpes zoster vaccine composition Inactive 23-Dec-2021
WO-2022089233-A1 Recombinant spike protein, and preparation method therefor and application thereof Inactive 30-Oct-2020
WO-2009132484-A1 Lytic proteins of vero cell, preparation method thereof and detection kit for vero hcp comprising the same Inactive 30-Apr-2008
US-20110256182-A1 Genes encoding major capsid protein l1 of human papilloma virus Active 23-Nov-2007 C07K14/025
To view Zerun Biotechnology’s complete patent history, request access »

Zerun Biotechnology Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zerun Biotechnology‘s full profile, request access.

Request a free trial

Zerun Biotechnology Investments (1)

Zerun Biotechnology’s most recent deal was a Corporate with Yidao Bio. The deal was made on 08-Jun-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Yidao Bio 08-Jun-2018 Corporate Drug Discovery
To view Zerun Biotechnology’s complete investments history, request access »

Zerun Biotechnology Exits (1)

Zerun Biotechnology’s most recent exit was on 08-Jun-2018 from Yidao Bio. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Yidao Bio 08-Jun-2018 Completed
To view Zerun Biotechnology’s complete exits history, request access »

Zerun Biotechnology FAQs

  • When was Zerun Biotechnology founded?

    Zerun Biotechnology was founded in 2003.

  • Where is Zerun Biotechnology headquartered?

    Zerun Biotechnology is headquartered in Shanghai, China.

  • What industry is Zerun Biotechnology in?

    Zerun Biotechnology’s primary industry is Drug Discovery.

  • Is Zerun Biotechnology a private or public company?

    Zerun Biotechnology is a Private company.

  • What is Zerun Biotechnology’s current revenue?

    The current revenue for Zerun Biotechnology is .

  • How much funding has Zerun Biotechnology raised over time?

    Zerun Biotechnology has raised $8.15M.

  • Who are Zerun Biotechnology’s investors?

    Green Living Equity Investment Fund, Tibet Jinsheng Shuoxing Capital, and Xinyu Fanglue Dehe Investment Management have invested in Zerun Biotechnology.

  • Who are Zerun Biotechnology’s competitors?

    Hummingbird Bioscience, AUM Biosciences, and KM Biologics are competitors of Zerun Biotechnology.

  • When was Zerun Biotechnology acquired?

    Zerun Biotechnology was acquired on 26-Jun-2026.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process